AR and breast neoplasm: Similar to that observed in ERα-positive MCF-7 breast tumour cells, RES inhibited DNA synthesis and modulated cell cycle progression in androgen receptor (AR)-positive LNCaP but not in AR-negative DU145 human prostate tumour cells (Hsieh and Wu, 1999; Kuwajerwala et al, 2002).